Rules-Based Medicine, Inc., SEC Filing for Initial Public Offering
On December 23, 2009, psychiatric biomarker developer, Rules-Based Medicine, Inc., in Austin, Texas, filed documents with the United States Security and
Exchange Commission (SEC) to offer its stock to the public in an Initial Public Offering
slated for mid-2010. The company seeks to raise $90 million. It
applied to list its stock on the NASDAQ Global Market under the symbol "RULE."
To download the file in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will
launch the file so that you can see the document and/or print it.
To download the file in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will
launch the file so that you can see the document and/or print it.